ADVERTISEMENT

ADVERTISEMENT

Pfizer/BioNTech seek FDA nod for new COVID boosters for children

The applications represent a step towards getting children vaccinated by a so-called bivalent vaccine, which targets both the original strain of the virus and the circulating BA.4 and BA.5

Thumbnail - Clinic.jpg
While the flu shot will be available for everyone six months of age and up, the Pfizer COVID vaccine will be available for everyone ages five and up. WDAY News file image
We are part of The Trust Project.

Pfizer Inc and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years.

The application comes just days after Moderna also applied for FDA authorization of its own Omicron-targeting shot in adolescents aged 12 to 17 years and children aged six to 11.

The applications represent a step towards getting children vaccinated by a so-called bivalent vaccine, which targets both the original strain of the virus and the circulating BA.4 and BA.5 subvariants of Omicron.

The rollout of bivalent booster doses for older age groups has been off to a slow start in the United States compared to the rollout of the first boosters last year, with 4.4 million doses administered so far.

Earlier in the month, the U.S. Centers for Disease Control and Prevention said it expects COVID-19 vaccine boosters targeting circulating variants of the virus to be available for children aged 5-11 years by mid-October.

ADVERTISEMENT

More Nation/World coverage:

______________________________________________________

This story was written by one of our partner news agencies. Forum Communications Company uses content from agencies such as Reuters, Kaiser Health News, Tribune News Service and others to provide a wider range of news to our readers. Learn more about the news services FCC uses here.

What to read next
After greeting top Democrats Nancy Pelosi and Chuck Schumer at the award ceremony held in the Capitol Building, Gladys and Ken Sicknick walked by McCarthy and McConnell without acknowledging them.
While the fine is not expected to be material for a company of the Trump Organization's size, the conviction by a jury could complicate its ability to do business by spooking lenders and partners.
The case has come to the Supreme Court at a time of heightened concern over U.S. election integrity in light of new voting restrictions pursued by Republican state legislatures.
Analysts say those votes likely tilted Democratic, which will require strong Election Day turnout by Walker's Republican supporters. Opinion polls have shown a narrow lead for Warnock.